次要终点包括IRC评估的总生存期(OS)和总缓解率(ORR)。

Secondary end points included overall survival (OS) and overall response rate (ORR) per IRC.

youdao

结果：FOXP3在肿瘤细胞中的表达与较差的总生存期有关，而且增加了FOXP3免疫染色强度。

Results: FOXP3 expression in tumors was associated with worse overall survival probability and the risk increased with increasing FOXP3 immunostaining intensity.

youdao

次要观察终点包括总生存期，安全性，患者对治疗设施的满意度和理解以及医疗资源的利用。

Secondary endpoints included overall survival, safety, patients' satisfaction with and perception of treatment convenience, and medical resource utilization.

youdao